Global High Potency API (HPAPI) Contract Manufacturing Market Report 2023-2029 with Strategic Insights - Environmentally Sustainable Contract Manufacturing of HPAPI at the Forefront
November 28, 2023 06:04 ET
|
Research and Markets
Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "Global High Potency API (HPAPI) Contract Manufacturing Market(2023 Edition): Analysis By Formulation (Injectables, Oral Solids, Lotions, Others), End...
United States Oral Solid Dosage Contract Manufacturing Market Analysis Report 2023-2030: Patient-Centric Medication Adherence Spurs Innovation in Oral Dosage Forms
November 27, 2023 04:53 ET
|
Research and Markets
Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The "U.S. Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Tablets, Capsules), By Mechanism...
Global Pharmaceutical Contract Manufacturing Market Research Report 2023: A $100+ Billion Industry by 2030 - Increased Trend of Outsourcing & High Uptake of Small Molecules Across Diverse Therapeutics
November 14, 2023 04:03 ET
|
Research and Markets
Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Contract Manufacturing Market - Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. Pharmaceutical...
Artificial Intelligence Revolutionizes Merchant API Manufacturing as Market Expands at 6.97% CAGR
November 10, 2023 08:28 ET
|
Research and Markets
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Merchant API Market (by Molecular Type, Segment, Type, Type of Synthesis, End-User, & Region): Insights and Forecast with Potential Impact...
Societal CDMO Reports Third Quarter 2023 Financial Results
November 08, 2023 16:05 ET
|
Societal CDMO, Inc.
Recorded Q3 Revenue of $23.6 Million Signed Multiple New Business Agreements with New and Existing Customers Closed Public Offering Raising Gross Proceeds of Approximately $8.3 Million Initiated...
Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
November 08, 2023 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Societal CDMO to Report Financial Results for Third Quarter 2023 on November 8, 2023
November 01, 2023 16:05 ET
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO)...
Enhancing Quality Oversight in Pharmaceutical Contract Manufacturing Organizations: Master CMO Quality Oversight in Pharma with Online Training Seminar
October 26, 2023 12:43 ET
|
Research and Markets
Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The "Enhancing Quality Oversight in Pharmaceutical Contract Manufacturing Organizations" training course has been added to ResearchAndMarkets.com's...
Pharmaceutical Continuous Manufacturing: Revolutionizing Drug Production for Efficiency and Quality
October 26, 2023 08:18 ET
|
Research and Markets
Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The "Pharmaceutical Continuous Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added...
Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility
October 17, 2023 08:05 ET
|
Avid Bioservices, Inc
Avid completes construction of cell and gene theapy facility bringing total revenue generating capacity to up to ~$400 Million annually